by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Tuesday, May 2, 2017
BRIEF-Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28
* Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28, and provides an update on its path forward into Phase 3
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment